drugset / Trial / NCT00329615

Insulin Treatment in Cancer Cachexia

NCT00329615

RandomizedParallel-groupOpen-labelTreatment

Summary

The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.

Timeline

Start
2000-01
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulatard Protein / enzyme biologic

Indications

No indication recorded.